Add BrightSurf on Google Email

Study shows positive psychological effects of hormone therapy in transgender individuals

A systematic review of hormone therapy's effects on transgender individuals found significant improvements in mental health status and quality of life after as little as 3-6 months of treatment. Researchers suggest that increased access to hormone therapy could help eliminate or reduce depression and anxiety in this population.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalTransgender Health·DateFeb 9, 2016

DHEA improves vaginal discomfort after menopause

In a phase III trial, DHEA showed significant improvements in vaginal discomfort after menopause, reducing pain with sex by 0.36 points and improving vaginal dryness by 0.27 points compared to a placebo. The treatment also led to increased superficial cells and decreased parabasal cells, indicating improved vaginal health.

SourceThe Menopause Society·JournalMenopause·DateJan 5, 2016

Study: Women can take blood thinners and hormones without higher blood clot, bleeding risk

A study published in the Journal of the American Society of Hematology found that women on blood thinners can take hormone-containing contraception or hormone replacement therapy without an increased risk of blood clots or uterine bleeding. The study analyzed data from 1,888 women and showed similar incidence rates of blood clots and a...

Sex change hormonal treatments alter brain chemistry

A new study in Biological Psychiatry finds that hormonal treatments for sex reassignment alter brain chemistry, increasing serotonin levels in female-to-male transsexuals and decreasing them in male-to-female transsexuals. These changes may explain why testosterone improves symptoms in some forms of depression.

SourceElsevier·JournalBiological Psychiatry·DateOct 8, 2015

Experts recommend assessing individual benefits, risks of menopausal therapies

The Endocrine Society published a Clinical Practice Guideline on treating menopausal symptoms, recommending that women assess their individual benefits and risks of hormone therapy. The guideline suggests using various therapies, including hormonal and non-hormonal options, to manage symptoms such as hot flashes and genitourinary issues.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateOct 7, 2015

Study of 83,000 veterans finds cardiovascular benefits to testosterone replacement

A study of over 83,000 veterans found that restoring normal testosterone levels through gels, patches, or injections reduced the risk of heart attack, stroke, and death. Men who achieved normal levels saw significant benefits in cardiovascular health, while those who did not attained normal levels did not experience similar reductions.

SourceVeterans Affairs Research Communications·JournalEuropean Heart Journal·DateAug 10, 2015

Education intervention with residents improves understanding of transgender issues

A study led by Boston University School of Medicine researchers found that educating medical residents about transgender identity improved their knowledge and willingness to assist with hormonal therapy. The intervention increased residents' willingness to provide care for transgender patients from 5% to 76% for female-to-male patients...

SourceBoston University School of Medicine·JournalEndocrine Practice·DateAug 10, 2015

Experts recommend tumor removal as first-line treatment for Cushing's syndrome

The Endocrine Society recommends tumor removal as the first-line treatment for endogenous Cushing's syndrome. This approach is optimal because it preserves the hypothalamic-pituitary-adrenal axis, which is crucial for the body's central stress response. Other treatment options include medication and radiation therapy.

SourceThe Endocrine Society·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJul 29, 2015

ED worsened, testosterone levels decreased by some treatments of prostate enlargement

Researchers found that finasteride treatment led to a marked decline in erectile function and testosterone levels, while tamsulosin therapy showed no adverse effects. The study highlights the need for careful consideration of sexual side effects when treating benign prostate enlargement with 5α reductase inhibitors.

SourceBoston University School of Medicine·JournalHormone Molecular Biology and Clinical Investigation·DateJun 12, 2015